Skip to main content
OpenTrials

Clinical trial condition

Hepatocellular Carcinoma (HCC)

Explore clinical trials studying Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.

230 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Hepatocellular Carcinoma (HCC) trial results

Recruiting

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

NCT07176650

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Oncology Physicians Network (OPN) - Los Alamitos /OPN Healthcare Glendale, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • D&H National Research Centers, LLC Margate, Florida, United States
View all 51 locations
View Trial Details
Recruiting

Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

NCT07469319

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations
  • Aarhus University Hospital Aarhus, Central Jutland, Denmark
  • Regional Hospital Gødstrup Herning, Central Jutland, Denmark
  • Horsens Regional Hospital Horsens, Central Jutland, Denmark
  • Randers Regional Hospital Randers, Central Jutland, Denmark
View Trial Details

Related conditions